Procalcitonin-guided antibiotic therapy for lung infections
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether using a blood test called procalcitonin (which measures infection levels) can help doctors decide when to start and stop antibiotics for a lower respiratory tract infection (like pneumonia or bronchitis). The goal is to see if this approach works as well as the standard way of prescribing antibiotics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a lower respiratory tract infection (such as pneumonia or bronchitis) that is likely caused by bacteria and needs antibiotics.
- You are admitted to a hospital unit such as Internal Medicine, Geriatrics, Infectious Disease, Pneumology, Semi Intensive Care, ICU, or Emergency Medicine.
- You agree to take part in the study and sign a consent form.
- You do not have a severely weakened immune system (except from corticosteroid use).
- You do not have another infection that requires long-term antibiotics, such as endocarditis or osteomyelitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of using a blood test called procalcitonin to decide when to start antibiotics in critically ill patients with a new infection. The goal is to reduce unnecessary antibiotic use while still effectively treating infections.
This study tests whether a blood test called procalcitonin can help doctors stop intravenous antibiotics earlier in young hospitalized children when an infection seems likely. The goal is to reduce unnecessary antibiotic exposure without missing serious infections.
This study is checking if a blood test for procalcitonin (a sign of infection) can help measure how severe bronchiectasis is in children. It aims to find a way to better understand and manage this lung condition.
This study looks at whether a blood test called procalcitonin, which measures inflammation, can help predict how well patients with infections will recover while in the hospital. It may help doctors better understand your condition and guide treatment.
This trial studies whether using the MeMed BV® blood test in the emergency room or urgent care can help doctors decide when antibiotics are (or are not) needed for suspected lung infections. It may help reduce unnecessary antibiotics while still treating infections when needed.
This trial tests whether using a blood test called 'PCT' can help doctors decide when to start or stop antibiotics in critically ill adult patients in the EICU. The goal is to reduce unnecessary antibiotic use while still effectively treating bacterial infections.
Hear when a new Lower Respiratory Tract Infection (LRTI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.